Correction: Hoshi et al. High Correlation among Brain-Derived Major Protein Levels in Cerebrospinal Fluid: Implication for Amyloid-Beta and Tau Protein Changes in Alzheimer’s Disease. Metabolites 2022, 12, 355-Reference-Cited by-同舟云学术

Correction: Hoshi et al. High Correlation among Brain-Derived Major Protein Levels in Cerebrospinal Fluid: Implication for Amyloid-Beta and Tau Protein Changes in Alzheimer’s Disease. Metabolites 2022, 12, 355

Published:2023-05-25 Issue:6 Volume:13 Page:685
ISSN:2218-1989
Container-title:Metabolites
language:en
Short-container-title:Metabolites

Author:

Hoshi Kyoka¹,Kanno Mayumi²,Abe Mitsunari³^ORCID,Murakami Takenobu³^ORCID,Ugawa Yoshikazu³,Goto Aya⁴^ORCID,Honda Takashi²,Saito Takashi⁵,Saido Takaomi C.⁵,Yamaguchi Yoshiki⁶^ORCID,Miyajima Masakazu⁷,Furukawa Katsutoshi⁸,Arai Hiroyuki⁸,Hashimoto Yasuhiro²

Affiliation:

1. Department of Biochemistry, Fukushima Medical University, Fukushima 960-1295, Japan

2. Department of Forensic Medicine, Fukushima Medical University, Fukushima 960-1295, Japan

3. Department of Neurology, Fukushima Medical University, Fukushima 960-1295, Japan

4. Center for Integrated Science and Humanities, Fukushima Medical University, Fukushima 960-1295, Japan

5. Laboratory of Proteolytic Neuroscience, RIKEN Center for Brain Science, Saitama 351-0198, Japan

6. Structural Glyocobiology Team, RIKEN Global Research Cluster, Saitama 351-0198, Japan

7. Department of Neurosurgery, Juntendo University, Tokyo 113-8421, Japan

8. Institute of Development, Aging and Cancer, Tohoku University, Miyagi 980-8575, Japan

Abstract

In the original publication [...]

Funder

Japan Agency for Medical Research and Development

Publisher

MDPI AG

Subject

Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

https://www.mdpi.com/2218-1989/13/6/685/pdf

Reference1 articles.

1. Hoshi, K., Kanno, M., Abe, M., Murakami, T., Ugawa, Y., Goto, A., Honda, T., Saito, T., Saido, T.C., and Yamaguchi, Y. (2022). High Correlation among Brain-Derived Major Protein Levels in Cerebrospinal Fluid: Implication for Amyloid-Beta and Tau Protein Changes in Alzheimer’s Disease. Metabolites, 12.